Pfizer Inc. (PFE) will probably climb 6.63 percent over the next 12 months, according to price target estimates compiled by finviz. Meanwhile, they have set a $54price as 12-month high target. This represents a whopping 26.97 percent increase from where shares are trading today. The 12-month median price target assigned by the analysts stands at $46, which represents a return potential of 8.16 percent when compared to the closing price of the stock of $42.53 on Friday, January 18. The lowest price target for the stock is $40 — slightly more than -5.95 percent from PFE’s current share price.
The stock is currently hovering around the first support level of $42.23. Below this, the next support is placed in the zone of $41.94. Till the time, the PFE stock trades above this level, bulls have nothing to fear. On momentum oscillators front, ‘RSI’ has touched 47.83 on daily chart, which may remain a cause for concern. If the price breaks below $41.94 level on closing basis, then we may see more profit booking and the stock may show further weakness. On the flipside, hitting the $42.85 mark may result into a pull-back move towards $43.18 level.
On 18th of January, Pfizer Inc. (NYSE:PFE) shares ended higher after a volatile session. The shares accumulated 0.06 points or 0.14 percent at $42.53 with a heavy trade volume of 36.609 million shares. After opening the session at $42.86, the shares went as high as $42.88 and as low as $42.26, the range within which the stock’s price traded throughout the day. The firm is left with a market cap of $250 billion and now has 5.88 billion shares outstanding. Pfizer Inc. (PFE) stock has gained 0.31 percent of market value in 21 trading days.
PFE stock has a trailing 3-year beta of 0.81, offering the possibility of a lower rate of return, but also posing less risk. The portion of a company’s profit allocated to each outstanding share of common stock was $2.4 a share in the trailing twelve months. The stock’s value has fallen -2.57 percent year to date (YTD) against a rise of 14.98 percent in 12 month’s time. The company’s shares still trade -8.48 percent away from its 1-year high of $46.47 and 28.1 percent up from 52-week low of $33.20. The average consensus rating on the company is 2.6, on a scale where 5 equates to a unanimous sell rating. In short, the mean analyst recommendations are calling this stock a sell.
Shares of Pfizer Inc. (PFE) are trading at a P/E ratio of 26.26 times earnings reported for the past 12 months. The industry PFE operates in has an average P/E of 30.48. Its P/E ratio went as low as 18.56X and as high as 29.07 over the 5-year span. Further, it is sporting a 4.68 on the Price-to-Sales ratio. Compare this with the industry average P/S of 4.12. 79.1 percent is the gross profit margin for Pfizer Inc. and operating margin sits at 26.4 percent. Along with this, the net profit margin is 44.6 percent.
Let’s take a look at some insider activity at Pfizer Inc. (NYSE:PFE) and see the pattern. The earliest insider trade took place on 08/13/2018. Olson Laurie J parted with a total of 10.21 thousand shares of company at average share price of $41. The total for the sales was set at $418.77 thousand. After this transaction, the Executive Vice President account balance stood at 78.2 thousand shares. The stock grew 3.73 percent since that insider sale. On 08/03/2018, Mackenzie Alexander R, Executive Vice President, sold 25.64 thousand shares at a price per share of $39.51. This removed 1.01 million shares from the insider’s fortune and the stock saw a 7.64 percent rally in value since the news became public. This transaction left 111.53 thousand shares in the Executive Vice President account.
On 08/01/2018, Executive Vice President Damelio Frank A performed a sale transaction worth $6.02 million. This sale at $40 each has eliminated 150.48 thousand shares from the insider’s portfolio position. Meanwhile, shares have recorded 6.33 percent increase since the transaction was reported. The insider now is left with 342.45 thousand shares remaining in the account. Lund-Jurgensen Kirsten, who performs the Executive Vice President job, sold 20.94 thousand shares for $838.52 thousand. The disposal occurred on 08/01/2018 was priced at $40.04 per share. The share price soared 6.22 percent since the reporting date. Lund-Jurgensen Kirsten now left with a stake of 4.64 thousand PFE stock worth $197.47 thousand after the insider selling.